Chat with us, powered by LiveChat

Therapeutic Vaccines Market (Vaccines Type - Auto Immune Diseases Vaccines, Neurological Disease Vaccines, Chronic Disease Vaccines, and Infectious Diseases Vaccines; Disease Indication - Pneumococcal Disease, DTP, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Hepatitis, MMR, Varicella, Dengue, and Other Disease Indications; Administration - Intramuscular and Subcutaneous Administration, Oral Administration, and Other Routes of Administration; End User - Pediatrics and Adults): Global Industry Analysis, Trends, Market Size and Forecasts to 2024

Therapeutic Vaccines Market (Vaccines Type - Auto Immune Diseases Vaccines, Neurological Disease Vaccines, Chronic Disease Vaccines, and Infectious Diseases Vaccines; Disease Indication - Pneumococcal Disease, DTP, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Hepatitis, MMR, Varicella, Dengue, and Other Disease Indications; Administration - Intramuscular and Subcutaneous Administration, Oral Administration, and Other Routes of Administration; End User - Pediatrics and Adults): Global Industry Analysis, Trends, Market Size and Forecasts to 2024

Report Code: HC0334 Category: Healthcare & Medical Devices Published: July, 2018

A recent report published by Infinium Global Research on therapeutic vaccines market provides in-depth analysis of segments and sub-segments in global as well as regional therapeutic vaccines market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional therapeutic vaccines market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global therapeutic vaccines market. According to the report, the global therapeutic vaccines market is projected to grow at a CAGR of 7.3% over the forecast period of 2018-2024.

 

Market insight

Therapeutic vaccines aren't used for prevention. Instead, they're used as a method of treatment. Therapeutic vaccines are used to stimulate the immune system to target infection or a type of diseased cells-such as a cancer cell. complications of chronic diseases such as pneumococcal disease, DTP, influenza, human papillomavirus, meningococcal disease, polio, hepatitis, and varicella dengue. It is accomplished by controlling the presence of viruses in the blood and reducing the viral set-point in infected people. According to the U.S. food and drug administration, promising results from clinical trials recently led to the approval of the first therapeutic cancer vaccine. According to the world health organization "allergen immunotherapy therapeutic vaccines for allergic diseases." the historical term allergen extract was changed to allergen vaccine to reflect the fact that allergen vaccines are used in medicine as immune modifiers.

 

The major driving factor such as the increasing occurrence of cancer, cardiovascular diseases, HIV infection, and various chronic diseases are boosting the therapeutic vaccines market. In addition, Increase in funding’s from the government for vaccine development and growing awareness among people for severe disease are the key factors escalating the growth of therapeutic vaccines market. However, the high cost associated with treatment is expected to hinder the growth of therapeutic vaccines market. Moreover, various pharmaceutical players in this market are extensively researching on the research & Development activities to develop novel vaccines for several diseases that may create growth opportunities for therapeutic vaccines market in the near future.

 

Among the geographies, North America is the leading contributor to the therapeutic vaccines market. The U.S has the largest market share in the North America region. Developed medical and healthcare infrastructure and increasing funding for research and development activities are the few factors augmenting the growth in the North America region. On the other hand, the Asia-Pacific region is anticipated to be the fastest growing market in the upcoming year owing to the increasing prevalence of various diseases, rising disposable income and rapidly growing aging population.

 

Segment Covered

The report on global therapeutic vaccines market covers segments such as vaccines type, disease indication, administration, and end user. On the basis of vaccines type the global therapeutic vaccines market is categorized into auto immune diseases vaccines, neurological disease vaccines, chronic disease vaccines, and infectious diseases vaccines. On the basis of disease indication, the global therapeutic vaccines market is categorized into pneumococcal disease, DTP, influenza, human papillomavirus, meningococcal disease, polio, hepatitis, MMR, varicella, and dengue. On the basis of administration, the global therapeutic vaccines market is categorized into intramuscular and subcutaneous administration, oral administration and other routes of administration. On the basis of end user the global therapeutic vaccines market is categorized into pediatrics and adults.

 

Geographic Coverage

The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. 


Therapeutic Vaccines Market


The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-Pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2018-2024.

 

Companies Profiled:

The report provides profiles of the companies in the global therapeutic vaccines market such as Pfizer, Inc., GlaxoSmithKline PLC., Merck & Co., Inc., Sanofi Pasteur SA, CSL Limited, Emergent Biosolutions, Inc., Johnson & Johnson, MedImmune, LLC (A Subsidiary of AstraZeneca), Astellas Pharma, Inc. and Serum Institute of India.

 
Report Highlights:

The report provides deep insights on demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the global therapeutic vaccines market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of therapeutic vaccines market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the therapeutic vaccines market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players. This report will help manufacturers, suppliers, and distributors of the therapeutic vaccines market to understand the present and future trends in this market and formulate their strategies accordingly.


CHOOSE LICENCE TYPE

Please Choose One of them.

© 2024. Infinium Global Research LLP. All Rights Reserved.